Lessons from a failed γ-secretase Alzheimer trial

De Strooper, Bart·2014·Cell

DOI 10.1016/j.cell.2014.10.016

Cited by (287)

Items 101–200 of 287

γ-Secretase inhibitors and modulators: Mechanistic insights into the function and regulation of γ-Secretase
Pengju Nie, Abhishek Vartak, Yue‐Ming Li · 2020 · Seminars in Cell and Developmental Biology
Molecular basis of selective amyloid‐β degrading enzymes in Alzheimer's disease
Joanna Żukowska, Stephen J. Moss, Vasanta Subramanian, K. Ravi Acharya · 2023 · FEBS Journal
Design of Pyridopyrazine-1,6-dione γ-Secretase Modulators that Align Potency, MDR Efflux Ratio, and Metabolic Stability
Martin Pettersson, Douglas S. Johnson, John M. Humphrey, Todd W. Butler, Christopher W. am Ende, Benjamin A. Fish, Michael Green, Gregory W. Kauffman, Patrick B. Mullins, Christopher J. O’Donnell et al. · 2015 · ACS Medicinal Chemistry Letters
Side-by-side comparison of Notch- and C83 binding to γ-secretase in a complete membrane model at physiological temperature
Budheswar Dehury, Ning Tang, Rukmankesh Mehra, Tom L. Blundell, Kasper P. Kepp · 2020 · RSC Advances
Soluble Gamma-secretase Modulators Attenuate Alzheimer's β-amyloid Pathology and Induce Conformational Changes in Presenilin 1
F. Raven, Joseph F. Ward, K. Zoltowska, Yu Wan, Enjana Bylykbashi, Sean J. Miller, Xunuo Shen, Se-Hoon Choi, Kevin D. Rynearson, O. Berezovska et al. · 2017 · EBioMedicine
Design, synthesis and biological evaluation of novel carboline-cinnamic acid hybrids as multifunctional agents for treatment of Alzheimer’s disease
Qinghong Liao, Qi Li, Yifan Zhao, Pan Hong Jiang, Yuhui Yan, Haopeng Sun, Wenyuan Liu, Feng Feng, Wei Qu · 2020 · Bioorganic Chemistry
Reversal of Calcium Dysregulation as Potential Approach for Treating Alzheimer's Disease
Попугаева Елена Александровна, Daria Chernyuk, Безпрозванный Илья Борисович · 2020 · Current Alzheimer Research
Dual Inhibitors of AChE and BACE-1 for Reducing Aβ in Alzheimer’s Disease: From In Silico to In Vivo
Stern, Noa, Gacs, Alexandra, Tátrai, Enikő, Flachner, Beáta, Hajdú, István, Dobi, Krisztina, Bágyi, István, Dormán, György, Lőrincz, Zsolt, Cseh, Sándor et al. · 2022 · International Journal of Molecular Sciences
The FDA-approved natural product dihydroergocristine reduces the production of the Alzheimer’s disease amyloid-β peptides
Xiling Lei, Jing Quan Yu, Qi Niu, Jianhua Liu, Patrick C. Fraering, Fang Wu · 2015 · Scientific Reports
Biotic/Abiotic Stress-Driven Alzheimer's Disease
Changqing Li, Qing Zheng, Qi Wang, Qing-Ping Zeng · 2016 · Frontiers in Cellular Neuroscience
Stem cell‐ and gene‐based therapies as potential candidates in Alzheimer's therapy
Seyede Atefe Hosseini, Rezvan Mohammadi, Somaye Noruzi, Yousef Mohamadi, Mitra Azizian, Seyed Mojta Mousavy, Faezeh Ghasemi, AmirReza Hesari, Amirhossein Sahebkar, Reza Salarinia et al. · 2018 · Journal of Cellular Biochemistry
γ-Secretase Studied by Atomistic Molecular Dynamics Simulations: Global Dynamics, Enzyme Activation, Water Distribution and Lipid Binding
Manuel Hitzenberger, Martin Zacharias · 2019 · Frontiers in Chemistry
Curcumin Derivative GT863 Inhibits Amyloid-Beta Production via Inhibition of Protein N-Glycosylation
Yasuomi Urano, Mina Takahachi, Ryo Higashiura, Hitomi Fujiwara, Satoru Funamoto, So Imai, Eugene Futai, Michiaki Okuda, Hachiro Sugimoto, Noriko Noguchi · 2020 · Cells
Stem cell therapies for Alzheimer's disease
Sheng‐Min Wang, Chang‐Uk Lee, Hyun Kook Lim · 2018 · Current Opinion in Psychiatry
The γ-secretase substrate proteome and its role in cell signaling regulation
Pengfei Hou, Magdalena Zielonka, Lutgarde Serneels, Anna Martínez‐Muriana, Nicola Fattorelli, Leen Wolfs, Suresh Kumar Poovathingal, Dries T’Syen, Sriram Balusu, Tom Theys et al. · 2023 · Molecular Cell
Signal peptide peptidase and SPP-like proteases - Possible therapeutic targets?
Torben Mentrup, Ann-Christine Loock, Regina Fluhrer, Bernd Schröder · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Ocular amyloid imaging at the crossroad of Alzheimer’s disease and age-related macular degeneration: implications for diagnosis and therapy
Sally Shin Yee Ong, Alan D. Proia, Heather Elizabeth Whitson, Sina Farsiu, Pudugramam Murali Doraiswamy, Eleonora Maries Lad · 2018 · Journal of Neurology
Proteomic Substrate Identification for Membrane Proteases in the Brain
Stephan A. Müller, Simone Dario Scilabra, Stefan F. Lichtenthaler · 2016 · Frontiers in Molecular Neuroscience
Current Opinion on the Role of Neurogenesis in the Therapeutic Strategies for Alzheimer Disease, Parkinson Disease, and Ischemic Stroke; Considering Neuronal Voiding Function
Myung‐Hoon Han, Eun-Hye Lee, Seong‐Ho Koh · 2016 · International Neurourology Journal
AβPeptide Originated from Platelets Promises New Strategy in Anti-Alzheimer’s Drug Development
Mikhail Y. Inyushin, Priscila Sanabria, Legier V. Rojas, Yuriy V. Kucheryavykh, Lilia Y. Kucheryavykh · 2017 · BioMed Research International
Unravelling protein aggregation as an ageing related process or a neuropathological response
Diogo Trigo, André Nadais, Odete A. B. da Cruz e Silva · 2019 · Ageing Research Reviews
Chinese herbal medicine Qinggongshoutao for the treatment of amnestic mild cognitive impairment: A 52‐week randomized controlled trial
Jinzhou Tian, Jing Shi, Mingqing Wei, Jingnian Ni, Zhiyong Fang, Jinyu Gao, Heng Wang, Hongjun Yao, Jintao Zhang, Juntao Li et al. · 2019 · Alzheimer s & Dementia Translational Research & Clinical Interventions
Intramembrane proteolysis within lysosomes.
B. Schröder, P. Saftig · 2016 · Ageing Research Reviews
Recent advances in therapeutics and drug delivery for the treatment of inner ear diseases: a patent review (2011-2015)
Kim Nguyen, Judith S. Kempfle, David H. Jung, Charles E. McKenna · 2016 · Expert Opinion on Therapeutic Patents
A dual-acting 5-HT6 receptor inverse agonist/MAO-B inhibitor displays glioprotective and pro-cognitive properties
Vittorio Canale, Katarzyna Grychowska, Rafał Kurczab, Mateusz Ryng, Abdul Raheem Keeri, Grzegorz Satała, Agnieszka Olejarz‐Maciej, Paulina Koczurkiewicz, Marcin Drop, Klaudia Blicharz-Futera et al. · 2020 · European Journal of Medicinal Chemistry
Versatile nanomaterials for Alzheimer’s disease: Pathogenesis inspired disease-modifying therapy
Xi, Yilong, Chen, Yun, Jin, Yi, Han, Guochen, Song, Mingjie, Song, Tingting, Shi, Yang, Tao, Ling, Huang, Zewei, Zhou, Jianping et al. · 2022 · Journal of Controlled Release
Alzheimer Disease Clinical Trials Targeting Amyloid
Allison Bethanne Reiss, Natalie Montufar, Joshua R. DeLeon, Aaron Pinkhasov, Irving H. Gomolin, Amy D. Glass, Hirra A. Arain, Mark M. Stecker · 2021 · The Neurologist
Multi-Target-Directed Cinnamic Acid Hybrids Targeting Alzheimer’s Disease
Aliki Drakontaeidi, Eleni A. Pontiki · 2024 · International Journal of Molecular Sciences
Discovery of Cellular Roles of Intramembrane Proteases
Hester A. Beard, Marta Barniol‐Xicota, Jian Yang, Steven H. L. Verhelst · 2019 · ACS Chemical Biology
Pharmacological Disruption of the Notch1 Transcriptional Complex Inhibits Tumor Growth by Selectively Targeting Cancer Stem Cells
Annamil Alvarez-Trotta, William Guerrant, Luisana Astudillo, Mohini Lahiry, Giulia Diluvio, Elena Shersher, Hugo Kaneku, David J. Robbins, Darren Orton, Anthony J. Capobianco · 2021 · Cancer Research
Structural Modeling of γ-Secretase Aβ n Complex Formation and Substrate Processing
Manuel Hitzenberger, Martin Zacharias · 2019 · ACS Chemical Neuroscience
Current status and future directions of clinical applications using iPS cells—focus on Japan
Hiraku Tsujimoto, Kenji Osafune · 2021 · FEBS Journal
Molecular basis for isoform-selective inhibition of presenilin-1 by MRK-560
Xuefei Guo, Yumeng Wang, Jiayao Zhou, Chen Jin, Jiaoni Wang, Bojun Jia, Dan Jing, Chuangye Yan, Jianlin Lei, Rui Zhou et al. · 2022 · Nature Communications
Alzheimer's Disease and Its Potential Alternative Therapeutics.
Brent R. Kisby, Juliet T. Jarrell, Agar Me, Cohen Ds, Rosin Er, Cahill Cm, Jack T. Rogers, Xudong Huang · 2019 · PubMed
Evolvability of Amyloidogenic Proteins in Human Brain
Makoto Hashimoto, Gilbert J. Ho, Shuei Sugama, Yoshiki Takamatsu, Yuka Shimizu, Takato Takenouchi, Masaaki Waragai, Eliezer Masliah · 2018 · Journal of Alzheimer s Disease
A quantitative model of human neurodegenerative diseases involving protein aggregation
Kasper P. Kepp · 2019 · Neurobiology of Aging
Peptides Derived from Growth Factors to Treat Alzheimer’s Disease
Suzanne Gascon, Jessica Jann, Chloé Langlois-Blais, Mélanie Plourde, Christine L. Lavoie, Nathalie Faucheux · 2021 · International Journal of Molecular Sciences
Effect of Chronic Stress Present in Fibroblasts Derived from Patients with a Sporadic Form of AD on Mitochondrial Function and Mitochondrial Turnover
Karolina Drabik, Dominika Malińska, Karolina Piecyk, Grażyna Dębska–Vielhaber, Stefan Vielhaber, Jerzy Duszyński, Joanna Szczepanowska · 2021 · Antioxidants
Aβ-degrading proteases:therapeutic potential in Alzheimer disease
M. Leissring · 2016 · CNS Drugs
The type II transmembrane serine protease matriptase cleaves the amyloid precursor protein and reduces its processing to β-amyloid peptide
Erwan Lanchec, Antoine Désilets, François Béliveau, Anthony Flamier, Shaimaa Mahmoud, Gilbert Bernier, Denis Gris, Richard Leduc, Christine L. Lavoie · 2017 · Journal of Biological Chemistry
Modulation of γ-Secretase Activity by a Carborane-Based Flurbiprofen Analogue
Stefan Saretz, Gabriele Basset, Liridona Useini, Markus Laube, Jens Pietzsch, Dijana Drača, Danijela Maksimović‐Ivanić, Johannes Trambauer, Harald Steiner, Evamarie Hey‐Hawkins · 2021 · Molecules
Inhibition of γ-Secretase Leads to an Increase in Presenilin-1
Aitana Sogorb-Esteve, M. García-Ayllón, M. Llansola, V. Felipo, K. Blennow, J. Sáez-Valero · 2017 · Molecular Neurobiology
Gamma secretase inhibitors: a patent review (2013 - 2015)
Kai Gu, Qi Li, Hongzhi Lin, Jie Zhu, Jun Mo, Siyu He, Xin Lü, Xueyang Jiang, Haopeng Sun · 2017 · Expert Opinion on Therapeutic Patents
Identification and drug-induced reversion of molecular signatures of Alzheimer’s disease onset and progression in AppNL-G-F, AppNL-F, and 3xTg-AD mouse models
Eduardo Pauls, Sergi Bayod, Lídia Mateo, Víctor Alcalde, Teresa Juan-Blanco, Marta Sánchez‐Soto, Takaomi C. Saido, Takashi Saito, Antonio Berenguer, Camille Stephan‐Otto Attolini et al. · 2021 · Genome Medicine
BACE-1 Inhibitors Targeting Alzheimer's Disease
Kadja Luana Chagas Monteiro, Marcone Gomes dos Santos Alcântara, Nathalia Monteiro Lins Freire, Esaú Marques Brandão, Vanessa Lima do Nascimento, Líbni Maísa dos Santos Viana, Thiago Mendonça de Aquino, Edeildo Ferreira da Silva‐Júnior · 2023 · Current Alzheimer Research
Exploring the clinical transition of engineered exosomes designed for intracellular delivery of therapeutic proteins
Minseong Kim, Hojun Choi, Deok‐Jin Jang, Hye‐Jung Kim, Yujin Sub, Heon Yung Gee, Chulhee Choi · 2024 · Stem Cells Translational Medicine
Discovery of a Novel, Potent Spirocyclic Series of γ-Secretase Inhibitors
Zhiqiang Zhao, Dmitri A. Pissarnitski, Hubert B. Josien, Wen‐Lian Wu, Ruo Xu, Hongmei Li, John W. Clader, Duane A. Burnett, Giuseppe Terracina, Lynn A. Hyde et al. · 2015 · Journal of Medicinal Chemistry
Recapitulating Amyloid ß and Tau Pathology in Human Neural Cell Culture Models—Clinical Implications
Se Hoon Choi, Young Hye Kim, Carla D’Avanzo, Jenna Aronson, Rudolph E. Tanzi, Doo Yeon Kim, Postdoc Associate, Professor · 2015 · touchREVIEWS in Neurology
Beyond immunotherapy: new approaches for disease modifying treatments for early Alzheimer’s disease
Myuri T. Ruthirakuhan, Nathan Herrmann, Ivonne Suridjan, Eleenor H Abraham, Ilan Farber, Krista L. Lanctôt · 2016 · Expert Opinion on Pharmacotherapy
Self-Assembly Molecular Chaperone to Concurrently Inhibit the Production and Aggregation of Amyloid β Peptide Associated with Alzheimer’s Disease
Fan Huang, Aoting Qu, Huiru Yang, Lin Zhu, Hao Zhou, Jianfeng Liu, Jiafu Long, Linqi Shi · 2018 · ACS Macro Letters
Nasal delivery of polymeric nanoDisc mobilizes a synergy of central and peripheral amyloid-β clearance to treat Alzheimer’s disease
Huaqing Zhang, Yun Chen, Miao Yu, Yilong Xi, Guochen Han, Yi Jin, G.-J. Wang, Xinzhu Sun, Jianping Zhou, Yang Ding · 2023 · Proceedings of the National Academy of Sciences
Selective inhibitors of the PSEN1–gamma-secretase complex
Lutgarde Serneels, Rajeshwar Narlawar, Laura Pérez‐Benito, Martí Municoy, Vı́ctor Guallar, Dries T’Syen, Maarten Dewilde, François Bischoff, Erwin Fraiponts, Gary Tresadern et al. · 2023 · Journal of Biological Chemistry
Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer’s disease
Jean‐François Blain, Matthew G. Bursavich, Emily A. Freeman, Lori Hrdlicka, Hilliary Hodgdon, Ting Chen, Don Costa, Bryce A. Harrison, Sudarshan Kapadnis, Deirdre A. Murphy et al. · 2016 · Alzheimer s Research & Therapy
Discovery of cyclopropyl chromane-derived pyridopyrazine-1,6-dione γ-secretase modulators with robust central efficacy
Martin Pettersson, Douglas S. Johnson, Danica A. Rankic, Gregory W. Kauffman, Christopher W. am Ende, Todd W. Butler, Brian P. Boscoe, Edelweiss Evrard, Christopher J. Helal, John M. Humphrey et al. · 2016 · MedChemComm
From defense to disease: IFITM3 in immunity and Alzheimer's disease
Zoe Kehs, Abigail C. Cross, Yue‐Ming Li · 2024 · Neurotherapeutics
Brain Organoids: Tiny Mirrors of Human Neurodevelopment and Neurological Disorders
Anuradha Yadav, Brashket Seth, Rajnish Kumar Chaturvedi · 2020 · The Neuroscientist
Stem cell-based therapy as a promising approach in Alzheimer's disease: current perspectives on novel treatment
Saeid Bagheri‐Mohammadi · 2021 · Cell and Tissue Banking
Structural and Chemical Biology of Presenilin Complexes
Douglas S. Johnson, Yue‐Ming Li, Martin Pettersson, Peter St George‐Hyslop · 2017 · Cold Spring Harbor Perspectives in Medicine
Modulation of amyloid precursor protein cleavage by γ-secretase activating protein through phase separation
Chen Jin, Jiaoni Wang, Yumeng Wang, Bojun Jia, Xuefei Guo, Guanghui Yang, Peng Xu, Paul Greengard, Rui Zhou, Yigong Shi · 2022 · Proceedings of the National Academy of Sciences
Proteases at work: cues for understanding neural development and degeneration
Paul Säftig · 2015 · Frontiers in Molecular Neuroscience
Smart treatment strategies for alleviating tauopathy and neuroinflammation to improve clinical outcome in Alzheimer's disease
Katyayani Tatiparti, Samaresh Sau, Mohd Ahmar Rauf, Arun K. Iyer · 2020 · Drug Discovery Today
Photopharmacology of Protease Inhibitors: Current Status and Perspectives
Jonathan Coene, Simon Wilms, Steven H. L. Verhelst · 2024 · Chemistry - A European Journal
Patterns of Innovation in Alzheimer’s Disease Drug Development: A Strategic Assessment Based on Technological Maturity
Jennifer M. Beierlein, Laura M. McNamee, Michael J. Walsh, Fred David Ledley · 2015 · Clinical Therapeutics
TrkA-mediated endocytosis of p75-CTF prevents cholinergic neuron death upon γ-secretase inhibition
María Luisa Franco, Irmina García-Carpio, Raquel Comaposada Baro, Juan Julián Escribano-Saiz, Lucía Chávez‐Gutiérrez, Marçal Vilar · 2021 · Life Science Alliance
Endotype reversal as a novel strategy for screening drugs targeting familial Alzheimer's disease
Andrew B. Caldwell, Qing Liu, Can Martin Zhang, Gary P. Schroth, Douglas R Galasko, Kevin D. Rynearson, Rudolph E. Tanzi, Shauna H. Yuan, Steven L. Wagner, Shankar Subramaniam · 2022 · Alzheimer s & Dementia
Amyloid-beta Targeted Therapeutic Approaches for Alzheimer’s Disease: Long Road Ahead
Yuxuan Dai, Chenyi Lei, Zhenhao Zhang, Yan Qi, Kejing Lao, Xingchun Gou · 2022 · Current Drug Targets
Single molecule imaging of protein aggregation in Dementia: Methods, insights and prospects
John S. H. Danial, David Klenerman · 2021 · Neurobiology of Disease
Screening and Characterization Strategies for Nanobodies Targeting Membrane Proteins
Sarah Veugelen, Maarten Dewilde, Bart De Strooper, Lucía Chávez‐Gutiérrez · 2016 · Methods in enzymology on CD-ROM/Methods in enzymology
Bax inhibitor 1 is a γ-secretase–independent presenilin-binding protein
Shenjie Wu, Wenqi Song, Catherine C. L. Wong, Yigong Shi · 2018 · Proceedings of the National Academy of Sciences
Eugenitol ameliorates memory impairments in 5XFAD mice by reducing Aβ plaques and neuroinflammation
Eunbi Cho, Kumju Youn, Huiyoung Kwon, Jieun Jeon, Wan‐Seob Cho, Se Jin Park, Seung Hwan Son, Dae Sik Jang, Chan Young Shin, Minho Moon et al. · 2022 · Biomedicine & Pharmacotherapy
Identification of Potential RBPJ-Specific Inhibitors for Blocking Notch Signaling in Breast Cancer Using a Drug Repurposing Strategy
Mengjie Rui, Min Cai, Yu Zhou, Wen Zhang, Lianglai Gao, Mi Ke, Wei Ji, Dan Wang, Chunlai Feng · 2022 · Pharmaceuticals
Rab21, a Novel PS1 Interactor, Regulates γ-Secretase Activity via PS1 Subcellular Distribution
Zhenzhen Sun, Yujie Xie, Yintong Chen, Qinghu Yang, Zhenzhen Quan, Rongji Dai, Hong Qing · 2017 · Molecular Neurobiology
The Main Targets Involved in Neuroprotection for the Treatment of Alzheimer’s Disease and Parkinson Disease
Hayrettin Ozan Gülcan, İlkay Erdoğan Orhan · 2020 · Current Pharmaceutical Design
Improved Neuroprotection Provided by Drug Combination in Neurons Exposed to Cell-Derived Soluble Amyloid-β Peptide
Julie Colin, Ahmad Allouche, Fabien Chauveau, Catherine Corbier, Lynn Gregory, Marie‐Claire Lanhers, Thomas Claudepierre, Frances T. Yen, Thierry Oster, Catherine Malaplate · 2016 · Journal of Alzheimer s Disease
Potent benzoazepinone γ-secretase modulators with improved bioavailability
Joey L. Methot, Christian Fischer, Chaomin Li, Alexey Rivkin, Sean P. Ahearn, William C. Brown, Solomon D. Kattar, Elizabeth H. Kelley, Dawn M. Mampreian, Adam Schell et al. · 2015 · Bioorganic & Medicinal Chemistry Letters
Gamma secretase modulators and BACE inhibitors reduce Aβ production without altering gene expression in Alzheimer’s disease iPSC-derived neurons and mice
Cusulin, Carlo, Wells, Isabelle, Badillo, Solveig, Duran-Pacheco, Gonzalo Christian, Baumann, Karlheinz, Patsch, Christoph · 2019 · Molecular and Cellular Neuroscience
BACE1 Translation: At the Crossroads Between Alzheimer’s Disease Neurodegeneration and Memory Consolidation
Francesc Xavier Guix, Carmem Luíza Sartório, Gerard ILL‐Raga · 2019 · Journal of Alzheimer s Disease Reports
Assembly of γ-secretase occurs through stable dimers after exit from the endoplasmic reticulum
Rosanne Wouters, Christine Michiels, Ragna Sannerud, Bertrand Kleizen, Katleen Dillen, Wendy Vermeire, Abril Escamilla‐Ayala, David Demedts, Randy W. Schekman, Wim G. Annaert · 2021 · The Journal of Cell Biology
Proteolytically generated soluble Tweak Receptor Fn14 is a blood biomarker for γ‐secretase activity
Gökhan Güner, Marlene Aßfalg, Kai Zhao, Tobias F. Dreyer, Shibojyoti Lahiri, Yun Lo, Bianca Ionela Slivinschi, Axel Imhof, Georg Jocher, Laura Strohm et al. · 2022 · EMBO Molecular Medicine
Analysis of Non-Amyloidogenic Mutations in APP Supports Loss of Function Hypothesis of Alzheimer’s Disease
Meewhi Kim, Безпрозванный Илья Борисович · 2023 · International Journal of Molecular Sciences
Pivotal trials for β-secretase inhibitors in Alzheimer's
Cormac Sheridan · 2015 · Nature Biotechnology
Can Arginase Inhibitors Be the Answer to Therapeutic Challenges in Alzheimer's Disease?
Saak Victor Ovsepian, Valerie B. O’Leary · 2018 · Neurotherapeutics
The de-Alzheimerization of age-related dementias: implications for drug targets and approaches to effective therapeutics
Kevin Mullane, Michael J. Williams · 2019 · Current Opinion in Pharmacology
Nanotechnology Therapy for Alzheimer′s Disease Memory Impairment Attenuation
Samo Ribarič · 2021 · International Journal of Molecular Sciences
Conformational Models of APP Processing by Gamma Secretase Based on Analysis of Pathogenic Mutations
Meewhi Kim, Безпрозванный Илья Борисович · 2021 · International Journal of Molecular Sciences
CD51 Intracellular Domain Promotes Cancer Cell Neurotropism through Interacting with Transcription Factor NR4A3 in Colorectal Cancer
Tianze Huang, Yanyun Lin, Junguo Chen, Jiancong Hu, Hao Chen, Yanhong Zhang, Bin Zhang, Xiaosheng He · 2023 · Cancers
Paradoxical effects of mutant ubiquitin on Aβ plaque formation in an Alzheimer mouse model
Bert M. Verheijen, Jo Stevens, Romina J. G. Gentier, Christian D. van ‘t Hekke, Daniël van den Hove, Denise J. H. P. Hermes, Harry W.M. Steinbusch, Jan M. Ruijter, Marcus O.W. Grimm, Viola J. Haupenthal et al. · 2018 · Neurobiology of Aging
Structural basis of human γ-secretase inhibition by anticancer clinical compounds
Xuefei Guo, Haotian Li, Xiaoli Lu, Hao Liu, U Kaicheng, Chuangye Yan, Jianlin Lei, Jing Huang, Rui Zhou, Yigong Shi · 2024 · Nature Structural & Molecular Biology
A Pentacyclic Triterpene from Ligustrum lucidum Targets γ-Secretase
Wenjie Luo, Fanny C.F. Ip, Guangmiao Fu, Kit Cheung, Yuan Tian, Yue‐Qing Hu, Anjana Sinha, Elaine Y. L. Cheng, Xianzhong Wu, Victor Bustos et al. · 2020 · ACS Chemical Neuroscience
Understanding familial Alzheimer's disease: The fit‐stay‐trim mechanism of γ‐secretase
Rukmankesh Mehra, Kasper P. Kepp · 2021 · Wiley Interdisciplinary Reviews Computational Molecular Science
Multimer Detection System-Oligomerized Amyloid Beta (MDS-OAβ): A Plasma-Based Biomarker Differentiates Alzheimer’s Disease from Other Etiologies of Dementia
Jacqueline C. Dominguez, Jeryl Ritzi T. Yu, Ma. Fe De Guzman, Encarnita Raya Ampil, Anne Cristine Guevarra, Ma. Lourdes C. Joson, Macario Reandelar, M Martinez, Antonio D. Ligsay, Ferron F. Ocampo et al. · 2022 · International Journal of Alzheimer s Disease
Discovery of thienopyrrolotriazine derivatives to protect mitochondrial function against Aβ-induced neurotoxicity
Tae-Hun Kim, Woo Seung Son, Mohammad Neaz Morshed, Ashwini M. Londhe, Seo Yun Jung, Jong‐Hyun Park, Woo‐Kyu Park, Sang Min Lim, Ki Duk Park, Sung Jin Cho et al. · 2017 · European Journal of Medicinal Chemistry
The amyloid-β peptide: Guilty as charged?
Michael Paul Murphy, Valeria A. Buzinova, Carrie E. Johnson · 2023 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
APLP1 as a cerebrospinal fluid biomarker for γ-secretase modulator treatment
Simon Sjödin, Kerstin K. A. Andersson, Marc H. Mercken, Henrik Zetterberg, Herman Borghys, Kaj Blennow, Erik Portelius · 2015 · Alzheimer s Research & Therapy
γ-Secretase Modulators as Aβ42-Lowering Pharmacological Agents to Treat Alzheimer’s Disease
Douglas S. Johnson, Martin Pettersson · 2017 · Topics in medicinal chemistry
Comparative Efficacy of 3Dimensional (3D) Cell Culture Organoids Vs 2Dimensional (2D) Cell Cultures Vs Experimental Animal Models In Disease modeling, Drug development, And Drug Toxicity Testing
Santenna Chenchula, Sunil Kumar, Shoban Babu Varthya · 2019 · International Journal of Current Research and Review
Prototype of a Smart Microfluidic Platform for the Evaluation of SARS-Cov-2 Pathogenesis, Along with Estimation of the Effectiveness of Potential Drug Candidates and Antigen–Antibody Interactions in Convalescent Plasma Therapy
Nimisha Roy, Jyoti Kashyap, Deepti Verma, Rakesh K. Tyagi, Amit Prabhakar · 2020 · Transactions of Indian National Academy of Engineering
Discovery of Clinical Candidate PF-06648671: A Potent γ-Secretase Modulator for the Treatment of Alzheimer’s Disease
Martin Pettersson, Douglas S. Johnson, John M. Humphrey, Christopher W. am Ende, Todd W. Butler, Peter H. Dorff, Ivan V. Efremov, Edelweiss Evrard, Michael Green, Christopher J. Helal et al. · 2024 · Journal of Medicinal Chemistry
γ‐Secretase modulators show selectivity for γ‐secretase–mediated amyloid precursor protein intramembrane processing
Tobias A. Weber, Johan Lundkvist, Johanna Wanngren, Hlin Kvartsberg, Shaobo Jin, Pia Larssen, Dan Wu, Daniel V. Oliveira, Karolina Minta, Gunnar Brinkmalm et al. · 2021 · Journal of Cellular and Molecular Medicine
Hidradenitis suppurativa secondary to treatment with a gamma secretase inhibitor
Elisa Ríos‐Viñuela, I. Hoyas‐Rodríguez, Daniella Cullen‐Aravena, Javier Martín‐Broto, Nadia Hindi, Itziar Eraña, Luis Requena · 2023 · Journal of the European Academy of Dermatology and Venereology